RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28062921http://www.w3.org/2000/01/rdf-schema#comment"

Aims/hypothesis

Administration of anti-CD40 ligand (CD40L) antibodies has been reported to allow long-term islet allograft survival in non-human primates without the need for exogenous immunosuppression. However, the use of anti-CD40L antibodies was associated with thromboembolic complications. Targeting downstream intracellular components shared between CD40 and other TNF family co-stimulatory molecules could bypass these complications. TNF receptor associated factor 2 (TRAF2) integrates multiple TNF receptor family signalling pathways that are critical for T cell activation and may be a central node of alloimmune responses.

Methods

T cell-specific Traf2-deficient mice (Traf2TKO) were generated to define the role of TRAF2 in CD4+ T cell effector responses that mediate islet allograft rejection in vivo. In vitro allograft responses were tested using mixed lymphocyte reactions and analysis of IFN-γ and granzyme B effector molecule expression. T cell function was assessed using anti-CD3/CD28-mediated proliferation and T cell polarisation studies.

Results

Traf2TKO mice exhibited permanent survival of full MHC-mismatched pancreatic islet allografts without exogenous immunosuppression. Traf2TKO CD4+ T cells exhibited reduced proliferation, activation and acquisition of effector function following T cell receptor stimulation; however, both Traf2TKO CD4+ and CD8+ T cells exhibited impaired alloantigen-mediated proliferation and acquisition of effector function. In polarisation studies, Traf2TKO CD4+ T cells preferentially converted to a T helper (Th)2 phenotype, but exhibited impaired Th17 differentiation. Without TRAF2, thymocytes exhibited dysregulated TNF-mediated induction of c-Jun N-terminal kinase (JNK) and canonical NFκB pathways. Critically, targeting TRAF2 in T cells did not impair the acute phase of CD8-dependent viral immunity. These data highlight a specific requirement for a TRAF2-NFκB and TRAF2-JNK signalling cascade in T cell activation and effector function in rejecting islet allografts.

Conclusion/interpretation

Targeting TRAF2 may be useful as a therapeutic approach for immunosuppression-free islet allograft survival that avoids the thromboembolic complications associated with the use of anti-CD40L antibodies."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.org/dc/terms/identifier"doi:10.1007/s00125-016-4198-7"xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Saito M."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Alexander S.I."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Watson K.A."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Villanueva J.E."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"La Gruta N.L."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Brink R."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Grey S.T."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Walters S.N."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Zammit N.W."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/author"Malle E.K."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/name"Diabetologia"xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/pages"679-689"xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/title"Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice."xsd:string
http://purl.uniprot.org/citations/28062921http://purl.uniprot.org/core/volume"60"xsd:string
http://purl.uniprot.org/citations/28062921http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28062921
http://purl.uniprot.org/citations/28062921http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28062921
http://purl.uniprot.org/uniprot/#_P39429-mappedCitation-28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28062921
http://purl.uniprot.org/uniprot/#_Q3U8L1-mappedCitation-28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28062921
http://purl.uniprot.org/uniprot/#_Q3TWR1-mappedCitation-28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28062921
http://purl.uniprot.org/uniprot/#_Q8C6X9-mappedCitation-28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28062921
http://purl.uniprot.org/uniprot/#_Q8CAQ7-mappedCitation-28062921http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28062921